Mercer Global Advisors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-38,721
| Closed | -$49.6K | – | 2120 |
|
|
2024
Q3 | $49.6K | Buy |
38,721
+7,500
| +24% | +$9.6K | ﹤0.01% | 1916 |
|
|
2024
Q2 | $31.8K | Buy |
31,221
+9,037
| +41% | +$9.22K | ﹤0.01% | 1931 |
|
|
2024
Q1 | $41K | Buy |
22,184
+2,498
| +13% | +$4.62K | ﹤0.01% | 1899 |
|
|
2023
Q4 | $24K | Sell |
19,686
-274
| -1% | -$334 | ﹤0.01% | 1985 |
|
|
2023
Q3 | $23K | Hold |
19,960
| – | – | ﹤0.01% | 1921 |
|
|
2023
Q2 | $18K | Buy |
+19,960
| New | +$18K | ﹤0.01% | 1897 |
|